Primary efficacy: Improved or cure with or without antibiotic modifications, defined as: survival at 7 days post randomization with resolution of fever and resolution of hypotension 7 days [clinicaltrials_resource:292ed45f5d91115e251abfb689a086c9]
Cotrimoxazole
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Primary efficacy: Improved or cure with or without antibiotic modifications, defined as: survival at 7 days post randomization with resolution of fever and resolution of hypotension 7 days [clinicaltrials_resource:292ed45f5d91115e251abfb689a086c9]
Cotrimoxazole
Bio2RDF identifier
292ed45f5d91115e251abfb689a086c9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:292ed45f5d91115e251abfb689a086c9
measure [clinicaltrials_vocabulary:measure]
Primary efficacy: Improved or ...... and resolution of hypotension
time frame [clinicaltrials_vocabulary:time-frame]
description
Cotrimoxazole
identifier
clinicaltrials_resource:292ed45f5d91115e251abfb689a086c9
title
Primary efficacy: Improved or ...... solution of hypotension 7 days
@en
type
label
Primary efficacy: Improved or ...... ed45f5d91115e251abfb689a086c9]
@en